Novel biomarkers of cardiovascular disease: applications in clinical practice

MN Lyngbakken, PL Myhre, H Røsjø… - Critical reviews in …, 2019 - Taylor & Francis
Measurement of biomarkers has revolutionized the work-up of patients with suspected
cardiovascular disease. The most widely used contemporary cardiovascular biomarkers are …

Cardiovascular biomarkers: lessons of the past and prospects for the future

F Omran, I Kyrou, F Osman, VG Lim… - International Journal of …, 2022 - mdpi.com
Cardiovascular diseases (CVDs) are a major healthcare burden on the population
worldwide. Early detection of this disease is important in prevention and treatment to …

Circulating biomarkers for cardiovascular disease risk prediction in patients with cardiovascular disease

YK Wong, HF Tse - Frontiers in Cardiovascular Medicine, 2021 - frontiersin.org
Cardiovascular disease (CVD) is the leading cause of death globally. Risk assessment is
crucial for identifying at-risk individuals who require immediate attention as well as to guide …

Effects of diet and sodium reduction on cardiac injury, strain, and inflammation: the DASH-sodium trial

SP Juraschek, LC Kovell, LJ Appel, ER Miller III… - Journal of the American …, 2021 - jacc.org
Abstract Background The DASH (Dietary Approaches to Stop Hypertension) diet has been
determined to have beneficial effects on cardiac biomarkers. The effects of sodium reduction …

Novel mouse model of myocardial infarction, plaque rupture, and stroke shows improved survival with myeloperoxidase inhibition

S Shamsuzzaman, RA Deaton, A Salamon, H Doviak… - Circulation, 2024 - ahajournals.org
BACKGROUND: Thromboembolic events, including myocardial infarction (MI) or stroke,
caused by the rupture or erosion of unstable atherosclerotic plaques are the leading cause …

A test in context: interpretation of high-sensitivity cardiac troponin assays in different clinical settings

I Raber, CP McCarthy, JL Januzzi Jr - Journal of the American College of …, 2021 - jacc.org
High-sensitivity cardiac troponin (hs-cTn) assays have the ability to detect minute troponin
concentrations and resolve minor changes in biomarker concentrations. Clinically, this …

Circulating microRNA as a biomarker for coronary artery disease

IT Fazmin, Z Achercouk, CE Edling, A Said… - Biomolecules, 2020 - mdpi.com
Coronary artery disease (CAD) is the leading cause of sudden cardiac death in adults, and
new methods of predicting disease and risk-stratifying patients will help guide intervention in …

High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without …

YK Wong, CYY Cheung, CS Tang, JJSH Hai… - Cardiovascular …, 2019 - Springer
Background High-sensitivity troponin I (hs-Tnl) and B-type natriuretic peptide (BNP) are
promising prognostic markers for coronary artery disease (CAD). This prospective cohort …

Association of high‐sensitivity troponin T and I blood concentrations with all‐cause mortality and cardiovascular outcome in stable patients—results from the …

B Bay, A Goßling, CM Blaum, F Kroeger… - Journal of the …, 2022 - Am Heart Assoc
Background The association between high‐sensitivity troponin T (hsTnT) and high‐
sensitivity troponin I (hsTnI) and outcome when adjusted for confounders including the …

High Sensitivity Troponin Level and Benefits of Chronic Total Occlusion Revascularization

DA Gold, PB Sandesara, V Jain, ME Gold… - Journal of the …, 2023 - Am Heart Assoc
Background The survival benefit of revascularization of chronic total occlusion (CTO) of the
coronary arteries remains a subject of controversy. We measured high sensitivity troponin‐I …